GlassScriptPhysician profile
Aura Veliz
NPI 1235276940
$17,868.97
in general payments reported to CMS, 2019-2025
23 companies · $552 in 2025
The $552 reported for 2025 was more than what 86% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $6,572 · 2022: $9,294 · 2023: $1,082 · 2024: $369 · 2025: $552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,003.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,002.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $13,957.67 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $1,062.66 | 2021 | |
| Abbvie INC. | $409.72 | 2021-2024 | |
| Novo Nordisk INC | $389.02 | 2022-2024 | Ozempic, Wegovy |
| Mayne Pharma Commercial LLC | $236.92 | 2025 | |
| Lilly USA, LLC | $176.48 | 2023-2024 | Mounjaro, Zepbound |
| Hologic Sales and Service, LLC | $168.46 | 2021-2024 | Aptima, Thinprep 2000 Processor |
| Amgen INC. | $149.98 | 2025 | Repatha |
| Scynexis, INC. | $132.44 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 2022 | |
| Astellas Pharma US INC | $125.00 | 2023 | Veozah |
| Lucid Diagnostics INC. | $122.68 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $121.88 | 2022 | |
| Biogen, INC. | $118.10 | 2025 | Zurzuvae |
| Genentech, INC. | $112.57 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $109.84 | 2024 | Onpattro |
| Bayer Healthcare Pharmaceuticals INC. | $98.85 | 2023 | |
| Philips North America LLC | $90.56 | 2023 | |
| Gilead Sciences, INC. | $60.86 | 2021-2023 | Descovy |
| Dexcom, INC. | $31.96 | 2024 | Dexcom G6 Transmitter |
| Viiv Healthcare Company | $28.74 | 2025 | Apretude |
| Pfizer INC. | $21.71 | 2023 | |
| Exact Sciences Corporation | $17.87 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aura Veliz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.